theory clinical_23_3
imports Main

begin

typedecl entity
typedecl event

consts
  Mutations :: "entity ⇒ bool"
  Activating :: "entity ⇒ bool"
  CTNNB1 :: "entity ⇒ bool"
  Proliferation :: "entity ⇒ bool"
  Cells :: "entity ⇒ bool"
  Promote :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Via :: "event ⇒ entity ⇒ bool"
  BetaCatenin :: "entity ⇒ bool"
  YAPInhibitor :: "entity ⇒ bool"
  Effective :: "entity ⇒ bool"
  Inhibiting :: "entity ⇒ bool"
  BetaCateninActivity :: "entity ⇒ bool"
  Reduce :: "event ⇒ bool"
  Cause :: "event ⇒ bool"
  Leads :: "event ⇒ bool"
  Treatment :: "entity ⇒ bool"
  Through :: "entity ⇒ entity ⇒ bool"
  To :: "event ⇒ entity ⇒ bool"
  Reducing :: "entity ⇒ bool"
  CellProliferation :: "entity ⇒ bool"
  By :: "event ⇒ entity ⇒ bool"
  Patients :: "entity ⇒ bool"
  Treating :: "entity ⇒ bool"

(* Explanation 1: Activating mutations of CTNNB1 promote proliferation of cells via β-catenin. *)
axiomatization where
  explanation_1: "∃x y z e. Mutations x ∧ Activating x ∧ CTNNB1 x ∧ Proliferation y ∧ Cells y ∧ Promote e ∧ Agent e x ∧ Patient e y ∧ Via e z ∧ BetaCatenin z"

(* Explanation 2: A YAP inhibitor may be effective in inhibiting β-catenin activity. *)
axiomatization where
  explanation_2: "∃x y. YAPInhibitor x ∧ Effective x ∧ Inhibiting y ∧ BetaCateninActivity y"

(* Explanation 3: Inhibiting β-catenin activity can reduce the proliferation of cells caused by activating mutations of CTNNB1. *)
axiomatization where
  explanation_3: "∃x y z e1 e2. Inhibiting x ∧ BetaCateninActivity x ∧ Proliferation y ∧ Cells y ∧ Reduce e1 ∧ Agent e1 x ∧ Patient e1 y ∧ Mutations z ∧ Activating z ∧ CTNNB1 z ∧ Cause e2 ∧ Agent e2 z ∧ Patient e2 y"

(* Explanation 4: Inhibiting β-catenin activity through a YAP inhibitor directly leads to effective treatment of patients with activating CTNNB1 mutations by reducing cell proliferation. *)
axiomatization where
  explanation_4: "∃x y z w e1 e2 e3. Inhibiting x ∧ BetaCateninActivity x ∧ YAPInhibitor y ∧ Through x y ∧ Leads e1 ∧ Agent e1 x ∧ Treatment z ∧ Effective z ∧ Patients z ∧ Mutations z ∧ Activating z ∧ CTNNB1 z ∧ To e1 z ∧ Reducing w ∧ CellProliferation w ∧ By e1 w"

theorem hypothesis:
  assumes asm: "YAPInhibitor x ∧ Patients y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y"
  (* Hypothesis: A YAP inhibitor may be effective in treating patients with activating CTNNB1 mutations. *)
  shows "∃x y. YAPInhibitor x ∧ Effective x ∧ Treating y ∧ Patients y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y"
proof -
  (* From the premise, we have the known information about YAP inhibitor and patients with activating CTNNB1 mutations. *)
  from asm have "YAPInhibitor x ∧ Patients y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y" by meson
  (* There is a logical relation Implies(D, E), Implies(YAP inhibitor, effective treatment of patients with activating CTNNB1 mutations) *)
  (* D is from explanatory sentence 2, E is from explanatory sentence 4. *)
  (* We already have YAPInhibitor x, so we can infer effective treatment of patients with activating CTNNB1 mutations. *)
  then have "Effective x ∧ Treating y ∧ Patients y ∧ Mutations y ∧ Activating y ∧ CTNNB1 y" sledgehammer
  then show ?thesis <ATP>
qed

end
